Dr Reddy’s seeks emergency use authorization for Russia’s Sputnik V vaccine

Dr. Reddy’s had been working with the Russian Direct Investment Fund (RDIF) to hold small domestic clinical studies of Sputnik V, which has proved 91.6% effective against COVID-19 based on late-stage trials in Russia.